CDSCO License for Applicator for nasopharynx remote after loading brachytherapy
Medical Device Information
Intended Use
A remote controlled brachytherapy applicator specifically designed for nasopharyngeal radiation therapy. It is designed to be temporarily implanted in the body. It serves as a guide for computer-controlled temporary placement and removal of a single or multiple therapeutic radiation sources in the nasopharynx.

Introduction: Understanding the Applicator for Nasopharynx Remote After Loading Brachytherapy and Its Regulatory Importance
The Applicator for Nasopharynx Remote After Loading Brachytherapy is a specialized medical device designed for precise, computer-controlled placement and removal of therapeutic radiation sources in the nasopharynx. As a Class C radiotherapy device, it demands stringent regulatory compliance to ensure patient safety and performance reliability. Navigating the CDSCO licensing process is critical for manufacturers and importers aiming to legally market this device in India.
With over 25 years of regulatory consulting experience and having supported 500+ companies in obtaining CDSCO licenses, we provide you with a detailed roadmap tailored to this device category.
CDSCO Regulatory Framework for Radiotherapy Applicators
The Central Drugs Standard Control Organization (CDSCO) regulates medical devices in India under the Medical Device Rules, 2017. Radiotherapy devices like your nasopharynx applicator fall under stringent scrutiny due to their invasive use and potential risk.
The device is notified under File No. 29/Misc./03/2020-DC (180) dated 6.8.2021, establishing its regulatory pathway. As a Class C device, it is regulated by the Central Licensing Authority and requires an MD9 manufacturing license.
Risk Classification and License Requirements for Class C Devices
Class C devices represent moderate to high risk, typically invasive or implantable devices with potential for significant patient impact. For your applicator, this classification means:
- Mandatory MD9 manufacturing license from CDSCO Central Licensing Authority.
- Compliance with comprehensive quality, safety, and efficacy standards.
- Submission of extensive technical documentation including risk management and clinical evaluation.
You can explore more about device classification on our detailed Medical Device Classification guide.
Manufacturing License Process (MD9) for Class C Devices
Obtaining an MD9 license is a multi-step process that typically takes 4-5 months. The key stages include:
- Test License (Form MD13): Initial step to manufacture the device for testing; processed within 1.5-2 months.
- Product Testing: Conducted at CDSCO-approved laboratories to verify compliance with applicable standards. Refer to the Testing Laboratories list for approved facilities.
- Document Preparation: Compilation of technical files, Device Master File, Plant Master File, and risk assessment documents.
- Application Submission (Form MD7): Formal request for MD9 license through the CDSCO MD Online Portal.
- Inspection and Audit: CDSCO inspectors perform on-site audits to verify compliance.
- Query Resolution: Addressing any issues raised during review.
- Grant of License (Form MD9): Final approval allowing commercial manufacture.
We recommend reviewing our comprehensive MD9 License Guide for step-by-step assistance.
Manufacturing License Documents Required
For Class C devices like the nasopharynx applicator, the following documents are essential:
- Company Constitution and Incorporation Certificates
- Proof of Premises Ownership or Lease
- Technical Staff Qualification and Experience Documents
- Fire Safety and Pollution Control NOCs
- Device Master File detailing design, manufacturing process, and specifications. Learn how to prepare it in our Device Master File Guide.
- Plant Master File describing manufacturing facilities and quality systems. See our Plant Master File Guide.
- Essential Principles Checklist confirming compliance with Indian standards
- Risk Management File outlining hazard analysis and mitigation strategies. We cover this extensively in our Risk Management guide.
- Product Test Reports from approved laboratories
- Labels and Instructions for Use (IFU)
- Quality Management System documentation, preferably ISO 13485:2016 certification
Preparing these documents with precision can significantly reduce processing delays.
Import License Process (MD15) for Nasopharynx Applicators
If you plan to import this device into India, an MD15 import license from CDSCO’s Central Licensing Authority is mandatory. The process generally takes 5-6 months and involves:
- Preparation of technical and regulatory dossiers.
- Submission of application on Form MD14 through the CDSCO MD Online Portal.
- Review of documents including Manufacturing License, Free Sale Certificate, ISO 13485:2016 and CE Certificates.
- Queries resolution.
- Final grant of MD15 license.
Document requirements include:
- Valid Manufacturing License (MD9)
- Free Sale Certificate from country of origin
- ISO 13485:2016 and CE Certification
- Device and Plant Master Files
- Wholesale License (if applicable)
- Company Constitution
Government fees vary by device class; for Class C devices, expect approximately 1500 per product.
Our detailed Import License Guide can assist you in navigating this process smoothly.
Timeline and Processing Duration
Stage | Duration |
---|---|
Test License (MD13) | 1.5 - 2 months |
Product Testing | 4 - 6 weeks |
Document Preparation | 1 - 2 months |
MD9 Application Submission | Immediate after docs |
Inspection and Audit | 1 month |
Query Resolution | 2 - 4 weeks |
Final License Grant | Upon clearance |
Overall, plan for a 4-5 month timeframe for manufacturing licensing and an additional 5-6 months if importing.
Government Fees and Costs
- MD9 License: ₹50,000 per application + ₹1,000 per product
- Test License (MD13): Included in MD9 process costs
- Import License (MD15): Approximately 1,500 per product for Class C
Budgeting for these fees early in your project is crucial.
Common Challenges and Solutions
- Incomplete Documentation: Many applicants face delays due to missing or poorly prepared files. Solution: Engage expert help and use detailed checklists.
- Lab Testing Delays: Limited capacity at government-approved labs can slow testing. Solution: Schedule tests early and consider multiple labs.
- Audit Non-Compliance: Facilities may fail audits due to gaps in QMS or safety standards. Solution: Conduct internal pre-audits and staff training.
- Query Backlogs: Delayed responses to CDSCO queries extend timelines. Solution: Assign dedicated regulatory personnel for prompt replies.
Expert Consultation and Support
Navigating regulatory pathways for Class C radiotherapy devices is complex. Our team, with 25+ years of experience, offers:
- Comprehensive dossier preparation
- Pre-audit readiness evaluation
- Liaison with CDSCO and notified bodies
- Customized regulatory strategy
Many clients have successfully launched their applicators in India with our guidance, avoiding costly pitfalls.
Getting Started with Your CDSCO License Application
- Assess your device classification confirming Class C status.
- Register on the CDSCO MD Online Portal to initiate applications.
- Engage a notified body or CDSCO-approved testing lab early for product evaluation.
- Prepare your Device and Plant Master Files meticulously.
- Obtain a Test License (MD13) to begin sample manufacturing.
- Collect test reports and finalize your technical documentation.
- Submit your MD9 license application (Form MD7).
- Prepare for and facilitate the CDSCO audit.
Starting early and following a structured approach will streamline your path to market. For personalized assistance, contact our regulatory consultants who specialize in medical device licensing in India.
By following this expert roadmap, manufacturers and importers of the nasopharynx remote after loading brachytherapy applicator can confidently achieve compliance and commercial success in the Indian medical device market.